LLY Competitors & Alternatives
Industry Overview
Eli Lilly and Company operates in the Drug Manufacturers - General industry within the Healthcare sector.
Competitor Comparison
| Company | Price | Market Cap | P/E Ratio | Div Yield | 1Y Return | Rating |
|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | $1,003.46 | $906.50B | 49.2 | 0.01% | +24.22% | |
| ABBV AbbVie Inc. | $217.11 | $395.66B | 165.7 | 0.03% | +24.56% | |
| AMGN Amgen Inc. | $366.20 | $170.91B | 24.4 | 0.03% | +18.53% | |
| AZN AstraZeneca PLC | $187.45 | $279.95B | 33.1 | 0.02% | — | |
| GILD Gilead Sciences, Inc. | $146.23 | $152.89B | 18.9 | 0.03% | +31.06% | |
| JNJ Johnson & Johnson | $234.47 | $505.78B | 20.3 | 0.02% | +32.53% | |
| MRK Merck & Co., Inc. | $118.34 | $248.84B | 13.0 | 0.03% | -2.09% | |
| NVO Novo Nordisk A/S | $47.19 | $223.45B | 12.8 | 0.04% | — | |
| NVS Novartis AG | $152.91 | $258.98B | 18.2 | 0.03% | — | |
| PFE Pfizer Inc. | $26.78 | $146.75B | 14.9 | 0.07% | +1.84% | |
| SNY Sanofi | $48.08 | $119.04B | 11.2 | 0.05% | — |
Compare LLY to Other Stocks
Use our stock comparison tool to analyze LLY against any other stocks side-by-side.
Compare Stocks
